SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-21-005803
Filing Date
2021-03-12
Accepted
2021-03-12 07:31:19
Documents
59
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K plxp20201231_10k.htm 10-K 1310262
2 EXHIBIT 4.6 ex_226884.htm EX-4.6 9409
3 EXHIBIT 21.1 ex_226885.htm EX-21.1 2982
4 EXHIBIT 23.1 ex_226886.htm EX-23.1 2837
5 EXHIBIT 31.1 ex_226887.htm EX-31.1 16670
6 EXHIBIT 31.2 ex_226888.htm EX-31.2 15748
7 EXHIBIT 32.1 ex_226889.htm EX-32.1 8775
14 ex_226884img001.gif GRAPHIC 5497
  Complete submission text file 0001437749-21-005803.txt   4992607

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT plxp-20201231.xml EX-101.INS 762362
9 XBRL TAXONOMY EXTENSION SCHEMA plxp-20201231.xsd EX-101.SCH 40903
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plxp-20201231_cal.xml EX-101.CAL 48579
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plxp-20201231_def.xml EX-101.DEF 358065
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE plxp-20201231_lab.xml EX-101.LAB 322315
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plxp-20201231_pre.xml EX-101.PRE 377043
Mailing Address 9 FISHERS LANE SUITE E SPARTA NJ 07871
Business Address 9 FISHERS LANE SUITE E SPARTA NJ 07871 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36351 | Film No.: 21735425
SIC: 2834 Pharmaceutical Preparations